Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment. | Sci Rep | 2023 | 37400463 | PubTator, text mining | PubMed |
| Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective. | Immunother Adv | 2023 | 37397971 | PubTator, text mining | PubMed |
| Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. | Genes Dis | 2023 | 37397537 | PubTator, text mining | PubMed |
| Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration. | Front Immunol | 2023 | 37383233 | PubTator, text mining | PubMed |
| Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes. | Cells | 2023 | 37371066 | PubTator, text mining | PubMed |
| Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37370768 | PubTator, text mining | PubMed |
| Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment. | Cancers (Basel) | 2023 | 37370757 | PubTator, text mining | PubMed |
| Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer. | EMBO Rep | 2023 | 37366231 | PubTator, text mining | PubMed |
| Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference. | Oncoimmunology | 2023 | 37363104 | PubTator, text mining | PubMed |
| Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma. | Heliyon | 2023 | 37360096 | PubTator, text mining | PubMed |
| Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. | Cell Rep | 2023 | 37355988 | PubTator, text mining | PubMed |
| NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cells. | Nat Commun | 2023 | 37349339 | PubTator, text mining | PubMed |
| Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling. | Nat Commun | 2023 | 37349293 | PubTator, text mining | PubMed |
| High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma. | Front Endocrinol (Lausanne) | 2023 | 37347110 | PubTator, text mining | PubMed |
| Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma. | Exp Ther Med | 2023 | 37346407 | PubTator, text mining | PubMed |
| The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? | Cancers (Basel) | 2023 | 37345131 | PubTator, text mining | PubMed |
| Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases. | Front Immunol | 2023 | 37342323 | PubTator, text mining | PubMed |
| The role of transcription factors in shaping regulatory T cell identity. | Nat Rev Immunol | 2023 | 37336954 | PubTator, text mining | PubMed |
| Targeting GITR in cancer immunotherapy - there is no perfect knowledge. | Oncotarget | 2023 | 37335294 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=25